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Summary. Recent investigations have demonstrated that
macrophage inhibitory protein 1a (MIP-1a) plays a critical
role in haematopoiesis. In part, MIP-1a limits the differ-
entiation of early haematopoietic cells, thereby ensuring that
suf®cient quantities of blood precursors are available to meet
haematopoietic demands. MIP-1a is produced by cells of the
marrow microenvironment (marrow stromal cells) in
response to a variety of stimuli, including interleukin 1b
(IL-1b) and tumour necrosis factor a (TNF-a). Our recent
investigations demonstrated that normal human osteoblast-
like cells (HOBs) maintain the early phenotype of haemato-
poietic precursors, like other members of the bone marrow
stroma. Although the precise molecular mechanisms for
these observations have not been determined, the production
of MIP-1a remains one such possibility. In the present study,
we investigated whether cells of the osteoblast lineage under
basal, IL-1b and/or TNF-a stimulation produce MIP-1a. We
observed that IL-1b and TNF-a stimulated HOBs and human
osteosarcoma cells to rapidly express MIP-1a mRNA and to
secrete large quantities of the protein. MIP-1a mRNA and
protein was not, however, detected under basal conditions.
Perhaps more importantly, enriched human CD34 bone
marrow cells in co-culture may be capable of stimulating the
expression of MIP-1a mRNA by HOBs in vitro. These ®ndings
suggest that human osteoblast-like cells may produce MIP-
1a in vivo to support haematopoiesis at sites where
osteoblasts and haematopoietic cells are closely associated.
Keywords: osteoblasts, haematopoiesis, microenvironment,
macrophage inhibitory protein 1a, bone marrow stromal
cells.
Normally, haematopoietic cell development depends upon
intimate interactions with the adherent cell populations of
the bone marrow. These cells, known collectively as bone
marrow stromal cells (BMSCs), include ®broblasts, adipo-
cytes, macrophages and endothelial cells. Although mor-
phologically distinct, all BMSCs probably display overlapping
haematopoietic activities. For example, most clonally derived
or mixed BMSC populations secrete low levels of granulo-
cyte/macrophage colony-stimulating factor (GM-CSF), acid
and basic ®broblast growth factors (FGF), tumour necrosis
factor a (TNF-a), transforming growth factor b (TGF-b),
stem cell factor (SCF) and interleukins (IL-1b, -4, -5, -6, -7,
-11, -17) to support basal haematopoiesis (Metcalf, 1988;
Roberts et al, 1988; Dexter et al, 1990; Hirano, 1990;
Ruscetti et al, 1991; Toksoz et al, 1992; Kittler &
Quesenberry, 1993). In the presence of in¯ammatory
monokines IL-1b and TNF-a, BMSCs secrete enhanced
quantities of G-CSF and GM-CSF (Guba et al, 1992; Fibbe
et al, 1988; Kittler et al, 1992). Differences are known in
vitro, particularly with regard to the ability to support early
haematopoietic cells. The distinctions may be due to the
differential expression of cell adhesion molecules, extracel-
lular matrix proteins and/or the production of novel
cytokines and inhibitors.
Osteoblasts are also members of the bone marrow
microenvironment. However, their role in haematopoiesis
has not yet been completely de®ned. Although it is widely
recognized that osteoblasts may regulate the activity and/or
development of osteoclasts, which are derived from
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haematopoietic precursors, there remains limited direct
evidence for a more global role of osteoblasts in haematopoi-
esis (Rodan & Martin, 1982; Fuller et al, 1991; Kassem et al,
1991; Roodman, 1991). Nevertheless, a substantial body of
evidence now shows that: (i) endosteal osteoblasts may share
a common precursor with other bone marrow stromal cells
(Dorheim et al, 1993); (ii) osteoblast-like cells produce
cytokines in vitro, which if produced in vivo would have
activities on haematopoietic cells (Gowen et al, 1990;
Littlewood et al, 1990; Felix et al, 1991; Birch et al, 1993;
Lacey et al, 1994; Taichman & Emerson, 1994); and (iii)
early haematopoietic precursors reside in close proximity to
endosteal surfaces (Lord & Hendry, 1972; Lord et al, 1975;
Gong, 1978; Deldar et al, 1985; Hermans et al, 1989; Lord,
1990; Cui et al, 1996).
We have begun to address the role of osteoblasts in
haematopoiesis by examining primary human osteoblast-
like cells (HOBs) for their ability to support the proliferation
and/or maintenance of human CD34 bone marrow cells.
We have observed that HOBs support the limited expansion
of long-term culture initiating cells (LTC-ICs) and haemato-
poietic progenitor cells in vitro (Taichman et al, 1996). In
part, these activities are probably mediated through the
secretion of soluble cytokines and through cell±cell adhe-
sions (unpublished observations). Moreover, the production
of IL-6 by HOBs is augmented by the presence of early
haematopoietic precursors bearing the CD34 marker in
vitro (Taichman et al, 1997). Additionally, like other
members of the bone marrow stroma, osteoblasts respond
to IL-1b and TNF-a by secreting enhanced cytokine levels
(Lacey et al, 1993; Avioli & Chaudhary, 1994). Together,
these ®ndings imply the existence of a functional dialogue
between osteoblasts and early haematopoietic precursors.
Recently, it was demonstrated that IL-1b and TNF-a
stimulate several BMSC lineages, including macrophages,
®broblasts, endothelial and T cells, to produce macrophage
in¯ammatory protein 1a (MIP-1a) (Wright et al, 1980;
Fahey et al, 1990; Eaves et al, 1993; Orolsky et al, 1995).
MIP-1a is a member of a group of cytokines best known for
their ability to attract host cells to sites of in¯ammation.
Consequently, MIP-1a is essential for the mounting of an
effective in¯ammatory response to viral infections (Cocchi
et al, 1995; Cook et al, 1995), although receptors for MIP-1a
may act as co-receptors for viral absorption (Atchison et al,
1996). In haematopoiesis, Lord et al (1976) ®rst demon-
strated that soluble factor(s) produced by BMSCs were
capable of inhibiting the proliferation of early haematopoie-
tic cells by demonstrating that rapidly proliferating haema-
topoietic spleen colony-forming cells (CFUs) were protected
from the lethal effects of large doses of tritiated thymidine.
Similar inhibitory effects were observed in long-term bone
marrow cultures (Toksoz et al, 1980). Later, Graham et al
(1990) identi®ed the active molecule as MIP-1a using
sequence analysis and speci®c antibody blockade. As an
inhibitor of stem cell proliferation, recent investigation has
focused upon the ability of MIP-1a to provide protection
from agents that target the DNA synthesis phase of the cell
cycle (Dunlop et al, 1992; Lord et al, 1992). Also important is
the recognition that most primitive haematopoietic cells are
normally quiescent in vivo, whereas their leukaemic counter-
parts maintain a rapid turnover. For this reason, the use of
MIP-1a is currently being examined for its ability to protect
stem cells against the effects of cytotoxic agents used for
therapy of rapidly proliferating leukaemic cells (Dunlop et al,
1992; Lord et al, 1992).
Although the precise molecular mechanisms with respect
to how osteoblasts support haematopoiesis have yet to be
determined, by virtue of the fact that osteoblasts maintain
LTC-ICs in vitro the production of MIP-1a remains one such
possibility. In bone, IL-1b or TNF-a are known to stimulate
bone resorption by osteoclasts in conjunction with soluble
activities produced by osteoblasts (Roodman, 1991). Further,
osteoclastic mobility is activated by MIP-1a (Fuller et al,
1995). Whether osteoblasts synthesize MIP-1a in response
to IL-1b or TNF-a remains unknown. Kukita et al (1992)
reported that MIP-1a mRNA is localized to osteoblasts in
bone-remodelling sites in the marrow and that osteoclasts
were frequently observed within the vicinity of these cells. If
osteoblasts synthesize MIP-1a then this protein may be part
of the normal mechanisms used by osteoblasts to regulate
bone resorption.
Based upon these observations, we hypothesized that
osteoblasts synthesize MIP-1a. We investigated whether
primary human osteoblast-like cells and several human
osteosarcoma cell lines expressed MIP-a mRNA or protein
under basal, IL-1b and/or TNF-a stimulation. We observed
that IL-1b and TNF-a stimulated cells of the osteoblastic
lineage to rapidly express MIP-1a mRNA and to secrete large
quantities of the protein. MIP-1a mRNA and protein was
not, however, detected under basal conditions. Perhaps more
importantly, enriched human CD34 bone marrow cells in
two out of three experiments stimulated the expression of
MIP-1a mRNA in mixed HOB/CD34 cell co-culture.
Together, these ®ndings suggest that human osteoblast-like
cells may produce MIP-1a in vivo to support haematopoiesis
at sites where osteoblasts and haematopoietic cells are
closely associated.
MATERIALS AND METHODS
Human osteoblast-like cells (HOBs) and osteosarcoma cell
lines. Enriched human osteoblast cultures were established
using modi®cations of the methods described by Robey &
Termine (1985). Normal human trabecular bone was
obtained from patients undergoing orthopaedic surgery in
accordance with the University of Michigan's Investigational
Review Board. Bone cleaned of loosely adherent tissue was
ground to produce a uniform particle size (size # 1 mm2;
BioComp Minimill, W. Lorenz, Jacksonville, FL, USA) and
incubated in 1 mg/ml bacterial collagenase (Type P, Boeh-
ringer Mannheim Biologicals, Indianapolis, IN, USA). The
explants were placed into culture until con¯uent monolayers
were produced in a 1:1 (v/v) mixture of Ham's F12/
Dulbecco's minimal essential medium (DMEM, Bio¯uids,
Rockville, MD, USA) with low Ca2 and 10% fetal bovine
serum (FBS). Thereafter, the cultures were maintained in
calcium-replete Ham's F12/DMEM (1:1 v/v) medium
containing 10% heat-inactivated FBS (Gibco BRL, Life
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Technologies Laboratories, Grand Island, NY, USA), anti-
biotics, 10 mM b-glycerol phosphate and 10 mg/ml L-ascor-
bate, hereafter referred to as experimental medium. To verify
that the cells expressed an osteoblast phenotype, the cultures
were screened for the expression of the osteoblast-speci®c
protein osteocalcin (osteocalcin) by reverse transcriptase
polymerase chain reaction (RT-PCR) as previously described
(Taichman & Emerson, 1994).
The human osteosarcoma cell lines HOS T85 (CRL1743),
MG-63 (ATCC CRL1424), SaOS-2 (ATCC 85-HTB) and U2-OS
(ATCC HTB96) were maintained in either MEM with Earle's
salts or McCoy's 5A medium with 10% heat-inactivated FBS.
For experiments, cells were plated to an initial density of
2´0 ´ 105 cells/cm2 with experimental medium changes on
days 5, 7, 10 and 14.
Human CD34 bone marrow cells and bone marrow stromal
cells. Human bone marrow cells were obtained from healthy
adult volunteers by iliac crest puncture and aspiration into
preservative-free heparin or from endosteal marrow scrap-
ings during orthopaedic surgery under a protocol approved
by the University of Michigan's Investigational Review
Board. Mononuclear cells were isolated by density separation
on Ficoll-Hypaque (speci®c gravity 1´077). Plastic adher-
ence at 378C was performed in Iscoves modi®ed Dulbecco's
medium (IMDM), 10% FBS, 10% equine serum, 1 mM
hydrocortisone, penicillin/streptomycin (Dexter et al, 1973;
Gibco BRL). Plastic adherent cells (BMSCs) were washed and
cultured until con¯uent. Mixed human bone marrow
stromal cells (BMSCs) were obtained as described and were
utilized after the third passage (Guba et al, 1992). For
experiments, cells were plated to an initial density of
2´0 ´ 104 cells/cm2 with experimental medium changes on
days 5, 7, 10 and 14. After overnight adherence, the non-
adherent cells were recovered and the CD34 bone marrow
cells were isolated by positive immunomagnetic selection
using the QUIND/10 antibody with the Mini-MACs System
(Miltenyi Biotec, Sunnyvale, CA, USA). Where possible, the
positive selected cells were stained with a phycoerythrin
conjugate of the anti-CD34 antibody HPCA-2 (Becton
Dickinson, San Jose, CA, USA) to evaluate purity by
¯uorescence activated cell sorting (EPICS C, Coulter Corp.
Hialeah, FL, USA). Under these conditions, 92´5 6 3´5%
(n2) of the recovered cells expressed the CD34 antigen.
Reverse transcriptase polymerase chain reaction (RT-PCR).
Total cellular RNA was recovered by lysing the cells directly
in Stat-60 according to the directions of the manufacturer
(Tel. Test, Friendswood, TX, USA). RNA integrity and purity
was checked by electrophoresis with ethidium bromide and
absorbency at A260/A280. RNA (1´0 mg), 10´ RT buffer (1´
RT buffer: 50 mM Tris, pH 8´3, 50 mM KCl, 8´0 mM MgCl2 and
10 mM dithiothreitol), 25 mM dXTP mix [25 mM of each dXTP
(ACGT)], 3´0 mg oligo-(dT), and 2´5 U reverse transcriptase
(M-MLV Reverse Transcriptase, Gibco BRL, Gaithersburg,
MD, USA) were incubated at 388C for 1 h. One-®fth of the
double-stranded product was then mixed with 10 ´ Taq/RT
buffer (1 ´ Taq/RT buffer: 10 mM Tris, pH 8´3, 50 mM KCl,
1´5 mM MgCl2, 0´01% gelatine and 2´0 mM dithiothreitol),
1 mM dXTP mix, 500 ng of each sense and antisense
oligonucleotide and 2´5 U Taq polymerase (AmpliTaq DNA
Polymerase; Perkin Elmer Cetus, Norwalk, CT, USA). The
samples underwent thermal cycling at 948C for 1 min, 608C
for 1 min and 728C for 2 min for 35 cycles, followed by a 10-
min extension at 728C (Perkin Elmer Cetus DNA thermal
cycler). The products were electrophoresed in 3% agarose
and visualized using ethidium bromide. Where indicated,
positive RNA specimens were included in the analyses. These
included IL-1b- and TNF-a-stimulated human bone marrow
stroma (MIP-1a), or in some cases E. coli lipopolysaccharide
(LPS) was utilized to stimulate MIP-1a expression in HOBs
(25 mg/ml, Sigma Chemical Co., St. Louis MO, USA). The
oligonucleotide synthesis centre at the University of Michi-
gan prepared the sense and antisense primers. To control for
false positives due to `overampli®cation' or DNA contamina-
tion, reverse transcriptase was omitted from selected
reactions and primers were designed to cross intron/exon
boundaries. The primers used in these investigations were:
MIP-1a, sense CTCAGAATCATGCAGGTCTCCA, antisense
GGCAACAACCAGTCCATAGAAG, expected size 405 bp
(Davatelis et al, 1989); b-actin, sense GTGGGGCGCCCCCA
GGCACCA, antisense CTCCTTAATGTCACGCACGATTTC,
expected size 548 bp, where the b-actin antisense primers
incorporated additional sequences for the T7 promotor; and
TGF-b1, sense ACCACTGCCGCACAACTCCGGTGAC, anti-
sense ATCTATGACAAGTTCAAGCAGAGTA, expected size
268 bp (Brenner et al, 1989).
Production of cell-conditioned medium. Con¯uent osteoblast-
like cells or osteosarcoma cell lines were washed twice and
fed with experimental medium. For cytokine stimulations,
IL-1b (0±250 pM), TNF-a (0±1´0 nM) or vehicle were added
directly to the cultures (R & D Systems, Minneapolis, MN,
USA). At 24, 48, 72 or 96 h, the conditioned medium was
harvested, spun at 12 000 r.p.m. at 48C for 15 min and
frozen at ±808C until further assay.
Co-culture of CD34 bone marrow cells and primary human
osteoblasts. Primary HOBs at con¯uence were harvested by
trypsinization (20 min, 378C, 0´05% trypsin/0´5 mM EDTA;
Gibco BRL) and seeded into 96-well or 24-well ¯at-bottomed
tissue culture plates to a ®nal density of 2 ´ 104/cm2 in
experimental medium. After 7 d, the HOBs monolayers were
washed twice and 1 ´ 104 CD34 bone marrow cells were
seeded onto the osteoblast monolayers. Thereafter, condi-
tioned medium was collected over the ®rst 120 h of the
osteoblast/blood cell co-culture. In some cases, CD34 bone
marrow cells (1´0 ´ 104) were seeded into the top chamber of
TransWellÒ (Corning Costar Corporation, Cambridge, MA,
USA) dual-chambered 24-well plates (0´4 mM pore size) with
con¯uent primary human osteoblasts in the bottom
chamber.
Cytokine enzyme-linked immunosorbent assays (ELISAs).
Conditioned medium was collected at the times indicated
and stored at ÿ808C until assayed for cytokine levels using
the double-antibody sandwich method assembled with
commercially available components according to the direc-
tions of the manufacturer (sensitivity 15´0 pg/ml, range
31´25±1000 pg/ml; R & D Systems). Cytokine levels are
presented as means 6 standard errors (mg/ml) for triplicate
determinations.
Statistical analyses. Arithmetic means and standard
deviations were calculated using INSTAT 1´14 (GraphPad, San
Diego, CA, USA) software, and presented as mean MIP-1a
(pg/ml) produced by HOBs (or osteosarcomas) in the absence
of IL-1b and TNF-a. Analysis of variance (ANOVA) was utilized
to determine statistical signi®cance to a level of P <0´05.
Turkey's HSD post hoc test was utilized for pairwise
comparisons.
RESULTS
Expression of MIP-1a and TGF-b1 mRNA by human
osteoblast-like cells (HOBs)
To determine whether primary HOBs or human osteo-
sarcoma cell lines express message for MIP-1a, cultures were
established over a 14-d period in the presence of L-ascorbate
and b-glycerol phosphate to facilitate the expression of a
mature osteoblast phenotype (Taichman & Emerson, 1996).
At the conclusion of the culture period, total cellular RNA
was isolated and examined for MIP-1a mRNA using RT-PCR.
As a positive control for MIP-1a expression, mixed bone
marrow stromal cells were cultured under similar conditions
and stimulated with IL-1b (250 pM) and TNF-a (1 nM) for
48 h. To control for our ability to detect similar sized
transcripts, matched samples were examined for TGF-b1
mRNA. Under these conditions, only the positive controls
expressed MIP-1a mRNA, however all of the cells examined,
including HOBs, HOS T85, MG-63, SaOS-2 and U2-OS,
expressed TGF-b1 transcripts (Fig 1).
As IL-1 and TNF-b have been implicated in the regulation
of bone resorption mediated through osteoblast-like cells
(Littlewood et al, 1991), the in¯ammatory monokines were
evaluated for their ability to induce the expression of MIP-1a
mRNA by cells of the osteoblastic lineage. For these
experiments, IL-1b and TNF-a were added in combination
to the cultures. At 48 h, total cellular RNA was isolated and
examined for MIP-1a expression. As shown in Fig 2, normal
human osteoblast-like cells expressed MIP-1a transcripts in
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Fig. 1. Human osteoblast-like cells (HOBs) and human osteosarcoma
cell lines do not constitutively express MIP-1a mRNA. Total cellular
RNA was isolated and examined for MIP-1a and TGF-b1 mRNA
transcripts by RT-PCR (35 cycles). As positive controls for MIP-1a
expression, mixed bone marrow stromal cells were cultured under
similar conditions and stimulated with IL-1b (250 pM) and TNF-a
(1 nM) for 48 h. To control for the ability to detect a similar sized
transcript, matched samples were examined for TGF-b1 mRNA.
Negative controls omitted reverse transcriptase from the positive
controls.
Fig. 2. IL-1b and TNF-a stimulate the expression of MIP-1a mRNA
by human osteoblast-like cells (HOBs). Total cellular RNA was
isolated from primary HOBs and examined for the expression of b-
actin or MIP-1a mRNA transcripts by RT-PCR (35 cycles). Where
indicated, HOBs cultures were stimulated with IL-1b (250 pM), TNF-
a (1 nM) or both for 48 h. To control for our ability to detect similar
sized transcripts, matched samples were examined for TGF-b1
mRNA As positive controls for MIP-1a expression, mixed bone
marrow stromal cells were cultured under similar conditions and
stimulated with IL-1b (250 pM) and TNF-a (1 nM) for 48 h or HOBs
were stimulated with Escherichia coli LPS (25 mg/ml) (Sigma
Chemical Co., St. Louis, MO, USA). For negative controls, reverse
transcriptase was omitted from the positive control.
Fig. 3. IL-1b and TNF-a stimulate the expression MIP-1a mRNA by
human MG-63 and SaOS-2 osteosarcomas. Total cellular RNA was
isolated from MG-63 and SaOS-2 osteosarcomas and examined for
MIP-1a transcripts by RT-PCR (35 cycles). Where indicated, the
osteosarcoma cultures were stimulated with IL-1b (250 pM), TNF-a
(1 nM) or both for 48 h. As positive controls for MIP-1a expression,
mixed bone marrow stromal cells were cultured under similar
conditions and stimulated with IL-1b (250 pM) and TNF-a (1 nM) for
48 h (data not presented). Negative controls omitted reverse
transcriptase from the positive control.
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response to IL-1b and TNF-a. IL-1b and TNF-a also induced
MIP-1a expression by MG-63 and SaOS-2 cells (Fig 3).
Similar data were obtained for HOBs, T85 and U2-OS (data
not presented).
To determine the time frame in which MIP-1a mRNA
expression occurs in response IL-1b and TNF-a, MG-63 and
SaOS0-2 cells were stimulated with IL-1b or TNF-a over a
72-h period. At various time points, RNA was collected and
reverse transcribed for PCR analysis. By 4 h, MIP-1a
transcripts were observed in response to both IL-1b and
TNF-a (Fig 4; data for the 24- to 72-h period are not
presented because all time points beyond 4 h were positive).
IL-1b or TNF-a also induced MIP-1a transcripts in Sa0S-2
cells (data not presented).
Secretion of MIP-1a protein by human osteoblast-like cells in
response to IL-1b or TNF-a stimulation
The preceding results suggested that osteoblasts do not
constitutively express MIP-1a mRNA, however MIP-1a
mRNA expression was rapidly induced by IL-1b or TNF-a.
Therefore, we next evaluated whether the MIP-1a mRNA is
translated. Here, primary HOBs were stimulated with IL-1b
and TNF-a and the levels of MIP-1a present in the
conditioned medium assayed by sandwich ELISA. As
shown in Fig 5, IL-1b stimulated the production of MIP-1a
(n3) protein for the three HOB isolates tested, although
considerable variation in the magnitude of the response was
observed. Similarly, TNF-a stimulation of the HOBs also
resulted in the production of MIP-1a. Together, IL-1b and
TNF-a stimulated MIP-1a production to a considerably
greater degree than either treatment alone (relative
expression of the combination; increase over IL-1b or TNF-
a alone was 61´8 6 9´8% and 91´1 6 8´7% respectively). No
MIP-1a protein was detected in the medium of unstimulated
HOBs.
To determine whether IL-1b and TNF-a also stimulated
MIP-1a production by MG-63 and SaOS-2 cells, these cell
lines cells were stimulated with log-fold serial dilutions of
IL-1b (0±250 pM) or TNF-a (0±1´0 nM) and the conditioned
medium was assayed for MIP-1a protein levels after 4 d. This
time point was selected as one in which protein accumula-
tion was most easily observed (data not presented). Both
IL-1b and TNF-a signi®cantly stimulated the accumulation
of MIP-1a protein in MG-63 and SaOS-2 culture super-
natants, however IL-1b was more potent in stimulating
MIP-1a production (Figs 6 and 7). Synergistic stimulation
(de®ned as more than additive) of MIP-1a production by IL-
1b and TNF-a was observed in some experiments, however
this was not a consistent ®nding.
Fig. 4. Time course for MIP-1a mRNA expression stimulated by IL-1b
and TNF-a MG-63 cells were stimulated with IL-1b (250 pM) or TNF-
a (1 nM) over the course of 72 h where a plus sign signi®es IL-1a or
TNF-a stimulation and a minus sign indicates vehicle controls. At
times 0, 0´5, 1, 2, 4, 10, 24, 48 and 72 h, total cellular RNA was
collected and examined for MIP-1a mRNA by RT-PCR. Data for the
24- to 72-h period were not presented, but were positive. Negative
controls omitted reverse transcriptase from the positive controls.
Fig. 5. IL-1b and TNF-a stimulates the secretion of MIP-1a by
human osteoblast-like (HOBs) cells. Primary HOBs from three
individuals were stimulated with IL-1b (250 pM), TNF-a (1 nM) or
both (combo) for 4 d. The levels of MIP-1a present in the conditioned
medium were assayed by sandwich ELISA. Results are reported as
means 6 standard deviations (n3). An asterisk indicates a
signi®cant difference from untreated controls (no treatment)
(P<0´05) as determined by ANOVA.
Fig. 6. IL-1b and TNF-a stimulate the secretion of MIP-1a by MG-63
cells. At con¯uence, MG-63 human osteosarcomas were stimulated
with log-serial dilutions of IL-1b (0±250 pM), TNF-a (0±1 nM) or
both for 4 d, and MIP-1a levels were assayed by sandwich ELISA.
Results are reported as means 6 standard deviations (n3). An
asterisk indicates signi®cant difference from untreated controls (no
Tx) (P<0´05) as determined by ANOVA. A plus sign indicates
synergistic interactions between IL-1 or TNF treatments (P<0´05)
as determined by ANOVA.
Normal human osteoblast-like cells may express MIP-1a
mRNA in response to human haematopoietic CD34 bone
marrow progenitors
Previously, we have noted that human bone marrow
haematopoietic CD34 cells were able to enhance the
levels of IL-6 produced by human osteoblast-like cells.
Other groups have reported that CD34 cells express
mRNA for IL-1b (Watari et al, 1996). As IL-1b and TNF-a
induce MIP-1a production, we hypothesized that human
osteoblasts would respond to the presence of early haema-
topoietic cells by producing MIP-1a. For these experiments,
explant-derived HOBs monolayers were seeded with enriched
human CD34 bone marrow cells either in direct contact or
separated from the HOBs by a porous micromembrane
(TransWellÒ). Over the 4-d period, immunoreactive MIP-1a
protein was not detected by ELISA, however MIP-1a mRNA
was expressed by the HOBs in direct contact with enriched
CD34 cell populations in two out of three experiments (Fig
8). Under conditions where osteoblasts and haematopoietic
cells were separated, in one of the two positive cases, MIP-1a
mRNA was expressed by the HOBs (Fig 8). Together these
data raise the possibility that osteoblasts may respond to the
presence of early haematopoietic cells by expressing MIP-1a
mRNA. No clear correlations could be drawn between the
expression of MIP-1a mRNA in the co-cultures and IL-1b
and TNF-a transcripts expressed by the haematopoietic cells
(data not shown).
DISCUSSION
Hematopoiesis is a tightly regulated process in which
specialized cells of the bone marrow microenvironment
produce both physiological inhibitors and stimulators of
early haematopoietic cells. As events localized to endosteal
surfaces are probably critical for the maintenance of
haematopoietic stem and progenitor cells, we have begun
to explore this tissue compartment with several models of
endosteal haematopoiesis. In the present study, we examined
osteoblast-like cells for their ability to produce MIP-1a. MIP-
1a is a member of a family of at least 10 cytokines of 8±
10 kDa exhibiting homology ranging from 20% to 45%.
Members of this family have both proin¯ammatory as well as
reparative activities. In addition, MIP-1a may inhibit the
progression of haematopoietic stem cells to the cell cycle
(Broxmeyer et al, 1991; Mancini et al, 1992; Eaves et al,
1993; Maltman et al, 1993; Verfaillie et al, 1994; Bonnet
et al, 1995; Mayani et al, 1995). The effects of MIP-1a,
however, appeared to be highly variable, depending upon the
maturational status of the target cells. For example, early
haematopoietic progenitors were maintained better in
cultures supplemented with MIP-1a and IL-3 (Verfaillie &
Miller, 1994; Verfaillie et al, 1994). MIP-1a did not inhibit
the ability of haematopoietic progenitors to form colonies,
but decreased the number of progenitors activated in
myelodepressed animals without a signi®cant effect on the
long-term reconstituting populations (Eaves et al, 1993;
Keller et al, 1994). On more mature populations, MIP-1a
may have few inhibitory effects (Mancini et al, 1992; Mayani
et al, 1995). In part, differences may be due to alterations of
receptor density and/or activation. Here, both high- and low-
af®nity receptors, with apparent molecular masses of 92 kDa
and 52 kDa, are expressed by haematopoietic cells (Avalos
et al, 1994). The Kd for the high-af®nity receptors correlates
with MIP-1a concentrations required to induce biological
effects on stem cells (Avalos et al, 1994). Receptors for MIP-
1a are present on cells enriched for CD34 expression from
patients with chronic myeloid leukaemia (CML) such that it
has been suggested that in vitro CML progenitor cells may be
refractory to the growth inhibitory effects of MIP-1a (Chasty
et al, 1995).
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Fig. 7. IL-1b and TNF-a stimulate the secretion of MIP-1a by SaOS-2
cells. At con¯uence, SaOS-2 human osteosarcomas were stimulated
with log-serial dilutions of IL-1b (0±250 pM), TNF-a (0±1 nM) or
both for 4 d, and MIP-1a levels were assayed by sandwich ELISA.
Results are reported as means 6 standard deviations (n3). An
asterisk indicates signi®cant difference from untreated controls (no
Tx) (P<0´05) as determined by ANOVA.
Fig. 8. CD34 bone marrow cells stimulate (RT-PCR) detection of
MIP-1a mRNA. CD34 bone marrow cells and primary HOBs were
cultured either alone or together in direct contact or separated by
porous micromembranes for 96 h in three independent experiments.
At the conclusion of the culture period, mRNA from osteoblasts only
(HOBs), mRNA from osteoblasts and CD34 cells in co-culture
(HOBs/CD34 contact), mRNA from osteoblasts recovered from dual-
chambered co-culture (HOBs/non-contact), mRNA from CD34
cells recovered from dual-chambered co-culture (CD34/non-con-
tact). Each sample was examined by RT-PCR for the expression of
MIP-1a or b-actin. Negative controls were by omission of reverse
transcriptase (not shown) from the reverse transcription reaction or
by use of H20. MW, molecular weight ladder.
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Previously, we observed that primary human osteoblast-
like cells support early blood cell lineages as assayed by the
maintenance of long-term culture initiating activity in vitro
(Taichman et al, 1996). As MIP-1a mRNA has been detected
in many members of the bone marrow microenvironment
cells including macrophages, ®broblasts and endothelial
cells, we hypothesized that osteoblast-like cells would also
express MIP-1a (Fahey et al, 1990; Eaves et al, 1993; Orolsky
et al, 1995). As such, we hypothesized that part of the
molecular basis for the ability of osteoblasts to support the
maintenance of early blood progenitors as immature cells
may be owing to MIP-1a.
In our in vitro experiments, we did not ®nd evidence for the
expression of MIP-1a mRNA in cells of the osteoblast lineage
in the absence of in¯ammatory stimuli. We therefore asked
whether the in¯ammatory cytokines IL-1b and TNF-a would
stimulate MIP-1a production. These in¯ammatory media-
tors were chosen because of their role in regulating
mineralized tissue metabolism (Dewhirst et al, 1986; Fibbe
et al, 1988; Linkhart et al, 1991; Chaudhary et al,
1992;Taichman & Hauschka, 1992; Avioli & Chaudhary,
1994) and mRNA for IL-1b has been characterized in early
human haematopoietic cells (Watari et al, 1996). We
observed that IL-1b and TNF-a stimulated the expression
MIP-1a mRNA in mixed populations of bone marrow
stromal cells, but more importantly we observed that
primary human osteoblast-like cells and several human
osteosarcoma cell lines expressed MIP-1a mRNA after the
cytokine stimulation. mRNA for MIP-1a was expressed as
early as 4 h in the cells examined (MG-63 and SaOS-2), but
signi®cant protein levels were not detected for 2±3 d
(unpublished observations).
Previously, it has been reported that CD34 cells express
mRNA for IL-1b (Watari et al, 1996). Therefore, we wished
to determined whether human osteoblasts respond to the IL-
1b produced by these early cells by producing MIP-1a.
Although MIP-1a protein was not detected in any of our co-
cultures, in some cases mRNA for MIP-1a was detected in
samples collected from mixed osteoblast/haematopoietic
cells. At present, it is not clear which of the cells in the
mixed culture (CD34 or HOBs) expressed the MIP-1a
mRNA. In this regard, CD34 bone marrow cells may
express MIP-1a mRNA, depending on the methods utilized to
isolate them (Watari et al, 1996). Just as likely, however,
remains the possibility that osteoblasts may themselves
express MIP-1a message in the co-culture because in one
case MIP-1a transcripts were expressed by HOBs that were
separated from the haematopoietic cells by porous micro-
membranes. Unfortunately, because of the small sample size
and the possibility of interpatient variability, we were not
able to determine whether the haematopoietic cells activated
the expression of MIP-1a mRNA through IL-1b or TNF-a
pathways (data not presented). Alternatively, it may be
possible that the CD34 cells stimulate MIP-1a production
through IL-1b- and TNF-a-independent pathways as was
observed when CD34 cells induced HOBs to secrete elevated
IL-6 (Taichman et al, 1997).
If MIP-1a protein is secreted by osteoblasts in co-cultures,
this activity may in part be responsible for the maintenance
of primitive haematopoietic cells in long-term cultures. As
defects in the responsiveness of CML neoplastic progenitors
to MIP-1a are believed to have an important role in their
uncontrolled proliferation, it would be as interesting to
determine whether differences exist among the ability of
haematopoietic progenitor cells to stimulate MIP-1a mRNA
(Chasty et al, 1995; Watari et al, 1996). Clearly, these
considerations will require further experimentation.
In summary, we demonstrated that primary human
osteoblast-like cells and osteosarcoma cell lines expressed
MIP-1a mRNA and secrete MIP-1a protein in response to IL-
1b and TNF-a exposure. Furthermore, human osteoblast-
like cells may produce MIP-1a in response to the presence of
early haematopoietic cell populations, although from our
data we could not correlate the expression of MIP-1a mRNA
with the expression of IL-1b and TNF-a transcripts by the
haematopoietic cells (data not presented). These ®ndings
suggest that in vivo human osteoblast-like cells may produce
MIP-1a to nevertheless support normal haematopoiesis
processes.
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